Mount Sinai Awarded $3 Million For Inflammatory Bowel Disease Center

Mount Sinai Awarded $3 Million For Inflammatory Bowel Disease Center
Founded by the renowned philanthropist and economist Sanford J. Grossman, The Sanford J. Grossman Charitable Trust was recently awarded $3 million to establish the Dr. Sanford J. Grossman Center for Integrative Studies in Inflammatory Bowel Disease at the Icahn School of Medicine at Mount Sinai. The Center will be focused on creating personalized medicine to address treatment for Crohn’s disease, and to better understand and predict the disease progression. Crohn’s Disease is an inflammatory chronic condition that affects the bowel, and was first described by the gastroenterologist Burrill B. Crohn working at Mount Sinai. It affects almost 700,000 Americans according to the Crohn’s & Colitis Foundation of America. Over time, persistent inflammation often leads to bowel damage and digestive complications can occur: the intestine's function can be compromised, resulting in reduced quality of life and higher need for surgical resection. “Mount Sinai has a large and unique data set on patients: clinical symptoms and history, pathology reports on resected gut tissue, genomics and family history, and radiology. My hope is that the integration and analysis of this data will enable a better understanding of the manifestations and natural histories of Crohn’s Disease, and with that knowledge, therapies will be developed to beneficially alter the natural course of the disease. At the very least, I hope that there will be a better understanding of the biological processes that lead to various types of stricture formation, and some suggestions as to how strictures can be prevented,”
Subscribe or to access all post and page content.